Can a new eye drop help contact lens wearers beat dry eye?
NCT ID NCT07054606
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether Miebo eye drops (perfluorohexyloctane) can safely and effectively relieve dry eye symptoms in people who wear soft contact lenses. 104 adults used the drops up to four times daily, both before and while wearing their lenses. Researchers measured changes in dry eye symptoms using a standard questionnaire.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
perfluorohexyloctane eye drops (Miebo)
What this could lead to
If it works, this could offer a new option for contact lens users to manage dry eye symptoms without removing their lenses.
What could go wrong
This is a small, completed Phase 4 trial with only 104 participants. Results may not apply to everyone, and the drops might not work for all types of dry eye.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 101
San Diego, California, 92307, United States
-
Site 102
Medina, Minnesota, 55340, United States
-
Site 103
Athens, Ohio, 45701, United States
-
Site 104
Pittsburg, Kansas, 66762, United States
-
Site 107
Longwood, Florida, 32779, United States
-
Site 108
Vestal, New York, 13850, United States